A Glimpse of Neogen's Earnings Potential
Portfolio Pulse from Benzinga Insights
Neogen (NASDAQ:NEOG) is set to release its quarterly earnings report on October 10, 2024, with analysts estimating an EPS of $0.08. The company's past performance has shown a tendency to miss estimates, impacting stock prices negatively. Neogen's stock is currently trading at $14.69, with a 52-week decline of 2.27%. Analysts have given Neogen a Neutral rating with a price target of $17.5, suggesting a potential upside. Compared to peers like Haemonetics, UFP Techs, and ICU Medical, Neogen ranks lower in revenue growth, gross profit, and return on equity.
October 09, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Neogen is set to release its earnings report with an expected EPS of $0.08. Past performance shows a tendency to miss estimates, affecting stock prices negatively. Analysts have given a Neutral rating with a price target of $17.5, indicating a potential upside.
Neogen's upcoming earnings report is crucial as past earnings misses have led to stock price declines. The Neutral analyst rating and potential upside suggest mixed expectations. Investors should watch for any surprises in the earnings report that could impact stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100